MiMedx Gets Favorable Court Ruling in FDA Treatment-Classification Dispute
By Katherine HamiltonMiMedx said it received a favorable ruling in its litigation challenging the Food and Drug Administration's classification of its wound treatment Axiofill.A Georgia district court ruled against the FDA's decision that Axiofill should be classified as a biological product rather…